These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1805731)

  • 1. Influence of inducers of cytochrome P-450 on dealkylation of 7-alkoxycoumarins.
    Müller D; Groh T; Splinter FK
    Arch Toxicol Suppl; 1991; 14():193-6. PubMed ID: 1805731
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of cytochrome P-450 type on the pattern of conjugation of 7-hydroxycoumarin generated from 7-alkoxycoumarins.
    Paterson P; Fry JR; Horner SA
    Xenobiotica; 1984 Nov; 14(11):849-59. PubMed ID: 6506757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and enzymatic comparison of hepatic cytochrome P-450 fractions from phenobarbital-, 3-methylcholanthrene-, beta-naphthoflavone- and 2,3,7,8- tetrachlorodibenzo-p-dioxin-treated rats.
    le Provost E; Cresteil T; Columelli S; Leroux JP
    Biochem Pharmacol; 1983 Jun; 32(11):1673-82. PubMed ID: 6870906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-Ethoxy-3,4-dimethylcoumarin: a substrate for a cytochrome P450-mediated mono-oxygenase activity that is highly induced by phenobarbitone and beta-naphthoflavone.
    Giurnazi AM; Garle MJ; Lal K; Fry JR
    J Pharm Pharmacol; 1996 Jul; 48(7):729-33. PubMed ID: 8866338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the effects of model inducers of cytochrome P450 on the biotransformation of scoparone in rat and hamster liver.
    Mennes WC; Luijckx NB; Wortelboer HM; Noordhoek J; Blaauboer BJ
    Arch Toxicol; 1993; 67(2):92-7. PubMed ID: 8481107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered induction response of hepatic cytochrome P-450 to phenobarbital, 3-methylcholanthrene, and beta-naphthoflavone in organotin-treated animals.
    Rosenberg DW; Sardana MK; Kappas A
    Biochem Pharmacol; 1985 Apr; 34(7):997-1005. PubMed ID: 3986002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-nitrosodialkylamine dealkylation in reconstituted systems containing cytochrome P-450 purified from phenobarbital- and beta-naphthoflavone-treated rats.
    Kawanishi T; Ohno Y; Takanaka A; Kawano S; Yamazoe Y; Kato R; Omori Y
    Arch Toxicol; 1992; 66(2):137-42. PubMed ID: 1605729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 7-alkoxyphenoxazones, 7-alkoxycoumarins and 7-alkoxyquinolines as fluorescent substrates for rainbow trout hepatic microsomes after treatment with various inducers.
    Haasch ML; Graf WK; Quardokus EM; Mayer RT; Lech JJ
    Biochem Pharmacol; 1994 Mar; 47(5):893-903. PubMed ID: 8135865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nifedipine on the enzyme-inducing activity of phenobarbital and beta-naphthoflavone.
    Koleva M; Staneva-Stoytcheva D
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):122-8. PubMed ID: 1819909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of isoniazid, phenobarbital, phenytoin, pregnenolone 16-alpha carbonitrile, and beta-naphthoflavone on halothane metabolism and hepatotoxicity.
    Jenner MA; Plummer JL; Cousins MJ
    Drug Metab Dispos; 1990; 18(5):819-22. PubMed ID: 1981743
    [No Abstract]   [Full Text] [Related]  

  • 12. Selectivity of 7-alkoxycoumarins as probe substrates for rat hepatic cytochrome P450 forms is influenced by the substitution pattern on the coumarin nucleus.
    Fry JR; Hammond AH; Jassi KL; Bass AE; Bruce G; Laughton C; Shaw PN; Bylov IE; Kovalenko SM
    Xenobiotica; 2004 Aug; 34(8):707-22. PubMed ID: 15690760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased response of cytochrome P-450 dependent biotransformation reactions in rat liver to repeated administration of inducers.
    Kleeberg U; Sommer M; Klinger W
    Arch Toxicol Suppl; 1985; 8():361-5. PubMed ID: 3868365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Aroclor 1254, phenobarbital, beta-naphthoflavone, and ethanol pretreatment on the biotransformation of cyclophosphamide in male and female rats.
    Sessink PJ; Vaes WH; van den Broek PH; de Roos JH; Noordhoek J; Bos RP
    Toxicology; 1996 Aug; 112(2):141-50. PubMed ID: 8814343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific induction of the carcinogen inducible cytochrome P450 isoform, P450IAI, in colonic epithelium.
    Rosenberg DW
    Arch Biochem Biophys; 1991 Jan; 284(1):223-6. PubMed ID: 1989500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities.
    Wortelboer HM; de Kruif CA; van Iersel AA; Falke HE; Noordhoek J; Blaauboer BJ
    Biochem Pharmacol; 1991 Jul; 42(2):381-90. PubMed ID: 1859452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver microsomal cytochrome P-450-dependent O-dealkylation reaction in various animals.
    Matsubara T; Otsubo S; Yoshihara E
    Jpn J Pharmacol; 1983 Oct; 33(5):1065-75. PubMed ID: 6645114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioselective O-demethylation of scoparone: differentiation between rat liver cytochrome P-450 isozymes.
    Müller-Enoch D; Büttgen E; Nonnenmacher A
    Z Naturforsch C Biosci; 1985; 40(9-10):682-4. PubMed ID: 4082729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of aging on hepatic microsomal monooxygenase induction by phenobarbital and beta-naphthoflavone.
    Rikans LE; Notley BA
    Biochem Pharmacol; 1982 Jul; 31(14):2339-43. PubMed ID: 6812588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of selective cytochrome P-450 inducing agents on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in rats.
    Tanaka E; Etoh H; Misawa S
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):375-8. PubMed ID: 2385760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.